Canbiocin

1 known investors

CanBiocin develops and manufactures synbiotic products combining prebiotics, probiotics, and postbiotics for functional health outcomes in animals, humans, and the environment. It acts as a contract development and manufacturing partner, offering strain discovery, custom formulation, processing technologies, and multiple delivery formats for brands.